Lilly, Biz Groups Rip Tribunal's Decision On 'Promise Doctrine'
U.S. drugmaker Eli Lilly has decried a recent ruling dismissing its claims brought under the North American Free Trade Agreement over Canada's controversial "promise utility doctrine" requiring patent holders to show...To view the full article, register now.
Already a subscriber? Click here to view full article